COMMON STOCK PURCHASE WARRANTOxis International Inc • January 13th, 2017 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _________________.; or its assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the "Initial Exercise Date") and on or prior to the close of business on the five (5) year anniversary of the date that the Company has reserved from its authorized and unissued shares of Common Stock such aggregate number of shares of Common Stock issuable upon the exercise in full of this Warrant (the "Termination Date") but not thereafter, to subscribe for and purchase from OXIS International, Inc., a Delaware corporation (the "Company"), up to __________ shares (as subject to adjustment hereunder, the "Warrant Shares") of Common Stock; provided, however, in the event that the number of shares of Common Stock reserved for the issuance of the Warrant Shares is less than the maximum number of Warran
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 13th, 2017 • Oxis International Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this "Agreement") is dated as of January 9, 2017, between OXIS International, Inc., a Delaware corporation (the "Company"), and the purchasers identified on the signature pages hereto (including its successors and assigns, a "Purchaser" and collectively, the "Purchasers").
10% SENIOR CONVERTIBLE DEBENTURE DUE JUNE 30, 2017Oxis International Inc • January 13th, 2017 • Pharmaceutical preparations • New York
THIS 10% SENIOR CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued 10% Senior Convertible Debentures of OXIS International, Inc., a Delaware corporation, (the "Company"), having its principal place of business at 100 South Ashley Drive, Suite 600, Tampa, FL 33602, designated as its 10% Senior Convertible Debenture due June 30, 2017 (this debenture, the "Debenture" and, collectively with the other debentures of such series, the "Debentures").
